Genome-wide Association Study Identifies Variants at CLU and PICALM Associated with Alzheimer's Disease

We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 cases and 7,848 controls), we replicated the established association with the apolipoprotein E (APOE) locus (most significant SNP, rs2075650, P = 1.8 x 10(-157)) and observed genome-wide significant association with SNPs at two loci not previously associated with the disease: at the CLU (also known as APOJ) gene (rs11136000, P = 1.4 x 10(-9)) and 5' to the PICALM gene (rs3851179, P = 1.9 x 10(-8)). These associations were replicated in stage 2 (2,023 cases and 2,340 controls), producing compelling evidence for association with Alzheimer's disease in the combined dataset (rs11136000, P = 8.5 x 10(-10), odds ratio = 0.86; rs3851179, P = 1.3 x 10(-9), odds ratio = 0.86).

Citing Articles

Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer's Disease.

Wei C, Zhang G, Fu X, Zhao M, Zhai W, Shen Y Mol Neurobiol. 2025; .

PMID: 40055292 DOI: 10.1007/s12035-025-04812-w.

Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.

Karati D, Meur S, Saha A, Saha T, Sen A Mol Neurobiol. 2025; .

PMID: 40044956 DOI: 10.1007/s12035-025-04806-8.

Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain-The Effects of Memantine.

Lewandowska M, Rozycka A, Grzelak T, Kempisty B, Jagodzinski P, Lianeri M Int J Mol Sci. 2025; 26(4).

PMID: 40004097 PMC: 11855568. DOI: 10.3390/ijms26041634.

A Massively Parallel CRISPR-Based Screening Platform for Modifiers of Neuronal Activity.

Boggess S, Gandhi V, Tsai M, Marzette E, Teyssier N, Yu-Ying Chou J bioRxiv. 2025; .

PMID: 39990495 PMC: 11844385. DOI: 10.1101/2024.02.28.582546.

Mechanisms of astrocyte aging in reactivity and disease.

Gildea H, Liddelow S Mol Neurodegener. 2025; 20(1):21.

PMID: 39979986 PMC: 11844071. DOI: 10.1186/s13024-025-00810-7.

References

Nordstedt C, Caporaso G, Thyberg J, Gandy S, Greengard P . Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells. J Biol Chem. 1993; 268(1):608-12. View

Dreyling M, Martinez-Climent J, Zheng M, Mao J, Rowley J, Bohlander S . The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci U S A. 1996; 93(10):4804-9. PMC: 39360. DOI: 10.1073/pnas.93.10.4804. View

Masliah E, Mallory M, Alford M, DeTeresa R, Hansen L, McKeel Jr D . Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 2001; 56(1):127-9. DOI: 10.1212/wnl.56.1.127. View

Koo E, Squazzo S . Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem. 1994; 269(26):17386-9. View

Cousin M, Robinson P . The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci. 2001; 24(11):659-65. DOI: 10.1016/s0166-2236(00)01930-5. View

Tycko B, Feng L, Nguyen L, Francis A, Hays A, Chung W . Polymorphisms in the human apolipoprotein-J/clusterin gene: ethnic variation and distribution in Alzheimer's disease. Hum Genet. 1996; 98(4):430-6. DOI: 10.1007/s004390050234. View

DeMattos R, Cirrito J, Parsadanian M, May P, ODell M, Taylor J . ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004; 41(2):193-202. DOI: 10.1016/s0896-6273(03)00850-x. View

Jones S, Jomary C . Clusterin. Int J Biochem Cell Biol. 2002; 34(5):427-31. DOI: 10.1016/s1357-2725(01)00155-8. View

Beecham G, Martin E, Li Y, Slifer M, Gilbert J, Haines J . Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am J Hum Genet. 2009; 84(1):35-43. PMC: 2668056. DOI: 10.1016/j.ajhg.2008.12.008. View

10.

Bell R, Sagare A, Friedman A, Bedi G, Holtzman D, Deane R . Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 2006; 27(5):909-18. PMC: 2853021. DOI: 10.1038/sj.jcbfm.9600419. View

11.

Moskvina V, Craddock N, Holmans P, Owen M, ODonovan M . Effects of differential genotyping error rate on the type I error probability of case-control studies. Hum Hered. 2006; 61(1):55-64. DOI: 10.1159/000092553. View

12.

Conde L, Vaquerizas J, Dopazo H, Arbiza L, Reumers J, Rousseau F . PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res. 2006; 34(Web Server issue):W621-5. PMC: 1538854. DOI: 10.1093/nar/gkl071. View

13.

Lambert M, Barlow A, Chromy B, Edwards C, Freed R, Liosatos M . Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998; 95(11):6448-53. PMC: 27787. DOI: 10.1073/pnas.95.11.6448. View

14.

Matsubara E, Soto C, Governale S, Frangione B, Ghiso J . Apolipoprotein J and Alzheimer's amyloid beta solubility. Biochem J. 1996; 316 ( Pt 2):671-9. PMC: 1217400. DOI: 10.1042/bj3160671. View

15.

Zeggini E, Scott L, Saxena R, Voight B, Marchini J, Hu T . Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008; 40(5):638-45. PMC: 2672416. DOI: 10.1038/ng.120. View

16.

Bertram L, Lange C, Mullin K, Parkinson M, Hsiao M, Hogan M . Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet. 2008; 83(5):623-32. PMC: 2668052. DOI: 10.1016/j.ajhg.2008.10.008. View

17.

Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J . Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech. 2000; 50(4):305-15. DOI: 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L. View

18.

Bales K, Verina T, Cummins D, Du Y, Dodel R, Saura J . Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 1999; 96(26):15233-8. PMC: 24803. DOI: 10.1073/pnas.96.26.15233. View

19.

Jenne D, Tschopp J . Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci. 1992; 17(4):154-9. DOI: 10.1016/0968-0004(92)90325-4. View

20.

Fitzjohn S, Morton R, Kuenzi F, Rosahl T, Shearman M, Lewis H . Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J Neurosci. 2001; 21(13):4691-8. PMC: 6762352. View